Trials / Completed
CompletedNCT01628159
LEVANT 2 Continuation Registry of the Lutonix® Drug Coated Balloon (DCB)
A Prospective, Multicenter, LEVANT 2 Continuation Registry of the Moxy™ Drug Coated Balloon for Treatment of Femoropopliteal Arteries
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 657 (actual)
- Sponsor
- C. R. Bard · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to collect additional safety and efficacy information on the Lutonix (formerly Moxy) Drug Coated Balloon for treatment of stenosis or occlusion of the femoral and popliteal arteries.
Detailed description
The purpose of the study is to collect additional safety and efficacy information on the Lutonix (formerly Moxy) Drug Coated Balloon for treatment of stenosis or occlusion of the femoral and popliteal arteries through 5 years.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Lutonix Drug Coated Balloon | balloon angioplasty with a drug coated balloon |
Timeline
- Start date
- 2012-06-01
- Primary completion
- 2018-09-01
- Completion
- 2018-12-01
- First posted
- 2012-06-26
- Last updated
- 2020-04-10
- Results posted
- 2020-04-10
Locations
64 sites across 5 countries: United States, Austria, Belgium, Germany, Switzerland
Source: ClinicalTrials.gov record NCT01628159. Inclusion in this directory is not an endorsement.